Govt.order Gen.edu.1968/2018 Dtd 28/05/2018
Appointment In Un Economic Schools
Search using Ctrl + F (Enter only date if you know the date of the order - Date format used is dd/mm/yyyy eg.
Bioequivalence based on (90% CI): Metformin. Waiver request of in-vivo testing: 500 mg based on (i) acceptable bioequivalence studies on the 1000 mg strength, (ii) acceptable dissolution testing across all strengths, and (iii) proportional similarity in the formulations across all strengths. Metformin hydrochloride extended-release tablets USP meets USP Dissolution Test 12. SYSTEM COMPONENTS AND PERFORMANCE Metformin hydrochloride extended-release tablet USP is designed for once-a-day oral administration using the swellable matrix coated with a permeable membrane technology. Dissolution test for metformin hydrochloride tablets. The dissolution profile of metformin tablets containing combinations of a hydrophilic polymer HPMC with Xanthan gum in the different polymer/polymer ratio (75:25, 50:50 and 25:75, respectively) while keeping the total polymer ratio 20% are shown in Figure 3. Formulations F6, F7 and F8 released 45.65, 26.84 and 26.93% of the drug, respectively, after 2 h and 96.32, 96.5 and 90.8% of the drug. Of Metformin Hydrochloride taken by the formula: Tolerances—Not less than 70% (Q) of the labeled amount of C 4H 11N 5 HCl is dissolved in 45 minutes. 0.1(r i /r S) TEST 2—If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 2.
Education Department Government Orders
HIGH COURT OF KARNATAKA-BENGALURU BENCHKARNATAKA HIGH COURT-BENGALURU BENCH DAILY CAUSE LISTIN THE HIGH COURT OF KARNATAKA AT BENGALURUON Friday THE 28TH DAY OF June 2019AT 10.30 AMBEFORETHE HON'BLE MR. JUSTICE ALOK ARADHECOURT HALL NO: 7LIST NO.